Neuroone Medical Technologies (NMTC) Income from Continuing Operations (2010 - 2026)
Neuroone Medical Technologies (NMTC) reported Income from Continuing Operations of 2382022.0 for Q1 2026, down 4.91% year-over-year from 2504935.1 in Q1 2025, and down 65.66% sequentially from 1437890.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies has disclosed Income from Continuing Operations across 17 years of filings, most recently posting 2382022.0 for Q1 2026.
- Quarterly Income from Continuing Operations fell 4.91% year-over-year to 2382022.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6940001.0 (down 5.1% YoY) and the FY2025 annual result came in at 3605374.0, up 70.73% from the prior year.
- Income from Continuing Operations slipped to 2382022.0 in Q1 2026, from 1437890.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 1785322.0 in Q4 2024 and bottomed at 3522828.0 in Q1 2023.
- The 5-year median for Income from Continuing Operations is 2759727.0 (2022), against an average of 2282060.29.
- Year-over-year, Income from Continuing Operations jumped 153.37% in 2024 and sank 180.54% in 2025.
- Neuroone Medical Technologies' Income from Continuing Operations stood at 1732769.0 in 2022, then sank by 93.04% to 3344900.0 in 2023, then jumped by 153.37% to 1785322.0 in 2024, then plunged by 180.54% to 1437890.0 in 2025, then sank by 65.66% to 2382022.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 2382022.0, 1437890.0, and 1619221.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Neuroone Medical Technologies | 26.73 Mn | 23.93 Mn | 990,264.00 | -2.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.38 Mn |
| Dec 31, 2025 | -1.44 Mn |
| Sep 30, 2025 | -1.62 Mn |
| Jun 30, 2025 | -1.50 Mn |
| Mar 31, 2025 | -2.27 Mn |
| Dec 31, 2024 | 1.79 Mn |
| Sep 30, 2024 | -3.35 Mn |
| Jun 30, 2024 | -2.77 Mn |
| Mar 31, 2024 | -2.86 Mn |
| Dec 31, 2023 | -3.34 Mn |
| Sep 30, 2023 | -3.14 Mn |
| Jun 30, 2023 | -3.47 Mn |
| Mar 31, 2023 | -3.52 Mn |
| Dec 31, 2022 | -1.73 Mn |
| Sep 30, 2022 | -1.37 Mn |
| Jun 30, 2022 | -2.76 Mn |
| Mar 31, 2022 | -3.06 Mn |
| Dec 31, 2021 | -2.81 Mn |
| Sep 30, 2021 | -2.64 Mn |
| Jun 30, 2021 | -2.95 Mn |